Trial intelligence / Profile preview

SARA: Saquinavir and Ritonavir PK in HIV-infected Pregnant Women

NCT00145561Phase 2Completed

Sponsor
Radboud University Medical Center
Start
Aug 2005
Primary completion
Jan 2008
Modality
Small Molecules
Countries
5
01

Overview

Phase 2, open-label trial of saquinavir in human immunodeficiency virus infection (HIV), sponsored by Radboud University Medical Center. Primary endpoint: Pharmacokinetics. Started Aug 2005; status: completed.

02

Drugs

saquinavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00145561.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00145561.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call